4 Battered Blue Chips Trading at Multiyear Lows Pay Huge High-Yield Dividends
Four blue-chip stocks are trading near their 52-week lows and offering investors incredible entry points and huge dividends.
Four blue-chip stocks are trading near their 52-week lows and offering investors incredible entry points and huge dividends.
Dividend stocks are one way to shield yourself from the market volatility. While all stocks carry a certain element of risk, dividend stocks generate steady income for you, ensuring you’re making your…
Dividend stocks are a smart way to navigate an uncertain market. Besides generating steady passive income, dividend-paying companies are also reliable and have a stable balance sheet that sustains the dividends. The…
Choosing dividend stocks is not only about looking at the yield but also ensuring that the company pays regular dividends, has a high dividend growth ratio and the payment is sustainable based…
Live Updates No Lucky No. 7 for the S&P 5004:08pm ETThe Vanguard S&P 500 ETF closed at 544.93 Tuesday, down 0.35%, breaking a six-day winning streak. Covid-19 Is Still a Thing11:42am…
These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains now.
Here are 24/7 Wall St.'s five favorite high-yield dividend stocks with which to start an investing portfolio.
Pfizer (NYSE:PFE | PFE Price Prediction) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13…
Amid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained highly volatile. The Fed will soon give an update on the economy and is expected…
With volatility taking center stage since the beginning of the year, investing in the stock market isn’t as easy as it was. Amid growing uncertainty, there is nothing like building a solid…
If you have an extra $5,000 to invest, you may want to consider beaten-down dividend stocks currently trading at a 52-week low. Not only can you benefit from their higher yields, but…
Eli Lilly (NYSE:LLY | LLY Price Prediction) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare…
As income and wealth inequality continue to divide Americans into two distinct classes and levels of wealth, those who are struggling to find investments that can outpace inflation and the growing costs…
Pfizer (NYSE:PFE | PFE Price Prediction) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster…
2025 hasn’t been kind to investors amid rising concerns about a recession and tariffs. There is a lot of uncertainty surrounding the economy, and this has impacted the stock market. But smart…